Scientific Reports (Nov 2022)

Isolongifolene-loaded chitosan nanoparticles synthesis and characterization for cancer treatment

  • Dharmar Manimaran,
  • Namasivayam Elangovan,
  • Panagal Mani,
  • Kumaran Subramanian,
  • Daoud Ali,
  • Saud Alarifi,
  • Chella Perumal Palanisamy,
  • Hongxia Zhang,
  • Kowsalya Rangasamy,
  • Vasan Palanisamy,
  • Renuka Mani,
  • Kavitha Govarthanan,
  • Wilson Aruni,
  • Rajeshkumar Shanmugam,
  • Guru Prasad Srinivasan,
  • Aruncahllam Kalirajan

DOI
https://doi.org/10.1038/s41598-022-23386-4
Journal volume & issue
Vol. 12, no. 1
pp. 1 – 13

Abstract

Read online

Abstract Recent breakthroughs in the field of nanoparticle-based therapeutic delivery methods have changed the standpoint of cancer therapy by effectively delaying the process of disease development. Nanoparticles have a unique capacity of good penetrating ability than other therapeutic leads used in traditional therapeutics, and also, they have the highest impact on disease management. In the current study isolongifolene-loaded Chitosan nanoparticles have been formulated, synthesized and then characterized by the use of Fourier Transform Infrared Spectroscopy, X-ray Diffraction, Scanning Electron Microscopy and Transmission Electron Microscopy. Further, the characterized chitosan nano formulation was evaluated for hemocompatibility, plasma stability, and in-vitro release. Isolongifolene-loaded chitosan nanoparticles were found to be compatible with plasma and also, they exhibited a constant release pattern. Hence, chitosan-loaded nanoparticles could be employed as an excellent adjuvant in cancer therapeutic, to combat the multi-drug resistance in solid tumors.